Biblio

Export 292 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
L. Saarelainen, Taipale, H., Koponen, M., Tanskanen, A., Tolppanen, A. - M., Tiihonen, J., and Hartikainen, S., The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 3, pp. 809-18, 2016.
T. Saari, Hallikainen, I., Hänninen, T., Räty, H., and Koivisto, A., Relationships between Cognition and Activities of Daily Living in Alzheimer's Disease During a 5-Year Follow-Up: ALSOVA Study., J Alzheimers Dis, vol. 64, no. 1, pp. 269-279, 2018.
M. N. Sabbagh, Schäuble, B., Anand, K., Richards, D., Murayama, S., Akatsu, H., Takao, M., Rowe, C. C., Masters, C. L., Barthel, H., Gertz, H. - J., Peters, O., Rasgon, N., Jovalekic, A., Sabri, O., Schulz-Schaeffer, W. J., and Seibyl, J., Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease., J Alzheimers Dis, vol. 56, no. 2, pp. 441-446, 2017.
G. Sacco, Caillaud, C., Ben Sadoun, G., Robert, P., David, R., and Brisswalter, J., Exercise Plus Cognitive Performance Over and Above Exercise Alone in Subjects with Mild Cognitive Impairment., J Alzheimers Dis, vol. 50, no. 1, pp. 19-25, 2016.
S. Sacuiu, Eckerström, M., Johansson, L., Kern, S., Sigström, R., Xinxin, G., Östling, S., and Skoog, I., Increased Risk of Dementia in Subjective Cognitive Decline if CT Brain Changes are Present., J Alzheimers Dis, vol. 66, no. 2, pp. 483-495, 2018.
D. Sadiq, Whitfield, T., Lee, L., Stevens, T., Costafreda, S., and Walker, Z., Prodromal Dementia with Lewy Bodies and Prodromal Alzheimer's Disease: A Comparison of the Cognitive and Clinical Profiles., J Alzheimers Dis, vol. 58, no. 2, pp. 463-470, 2017.
M. Safieh, Liraz, O., Ovadia, M., and Michaelson, D., The Role of Impaired Receptor Trafficking in Mediating the Pathological Effects of APOE4 in Alzheimer's Disease., J Alzheimers Dis, vol. 97, no. 2, pp. 753-775, 2024.
N. Sahara, Maeda, J., Ishikawa, A., Tokunaga, M., Suhara, T., and Higuchi, M., Microglial Activation During Pathogenesis of Tauopathy in rTg4510 Mice: Implications for the Early Diagnosis of Tauopathy., J Alzheimers Dis, vol. 64, no. s1, pp. S353-S359, 2018.
L. Sahin and Figueiro, M. G., Flickering Red-Light Stimulus for Promoting Coherent 40 Hz Neural Oscillation: A Feasibility Study., J Alzheimers Dis, vol. 75, no. 3, pp. 911-921, 2020.
A. Sahoo, Bejanin, A., Murray, M. E., Tosakulwong, N., Weigand, S. D., Serie, A. M., Senjem, M. L., Machulda, M. M., Parisi, J. E., Boeve, B. F., Knopman, D. S., Petersen, R. C., Dickson, D. W., Whitwell, J. L., and Josephs, K. A., TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia., J Alzheimers Dis, vol. 64, no. 4, pp. 1227-1233, 2018.
P. Paolo Sainaghi, Bellan, M., Lombino, F., Alciato, F., Carecchio, M., Galimberti, D., Fenoglio, C., Scarpini, E., Cantello, R., Pirisi, M., and Comi, C., Growth Arrest Specific 6 Concentration is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 55, no. 1, pp. 59-65, 2017.
N. Saji, Ishihara, Y., Murotani, K., Uchiyama, A., Takeda, A., Sakurai, T., and Matsushita, K., Cross-Sectional Analysis of Periodontal Disease and Cognitive Impairment Conducted in a Memory Clinic: The Pearl Study., J Alzheimers Dis, vol. 96, no. 1, pp. 369-380, 2023.
N. Sakae, Heckman, M. G., Vargas, E. R., Carrasquillo, M. M., Murray, M. E., Kasanuki, K., Ertekin-Taner, N., Younkin, S. G., and Dickson, D. W., Evaluation of Associations of Alzheimer's Disease Risk Variants that Are Highly Expressed in Microglia with Neuropathological Outcome Measures., J Alzheimers Dis, vol. 70, no. 3, pp. 659-666, 2019.
K. Sakai, Senda, T., Hata, R., Kuroda, M., Hasegawa, M., Kato, M., Abe, M., Kawaguchi, K., Nakai, S., Hiki, Y., Yuzawa, Y., and Kitaguchi, N., Patients that have Undergone Hemodialysis Exhibit Lower Amyloid Deposition in the Brain: Evidence Supporting a Therapeutic Strategy for Alzheimer's Disease by Removal of Blood Amyloid., J Alzheimers Dis, vol. 51, no. 4, pp. 997-1002, 2016.
N. Sakata and Okumura, Y., Job Loss After Diagnosis of Early-Onset Dementia: A Matched Cohort Study., J Alzheimers Dis, vol. 60, no. 4, pp. 1231-1235, 2017.
T. Saksida, Koprivica, I., Vujičić, M., Stošić-Grujičić, S., Perović, M., Kanazir, S., and Stojanović, I., Impaired IL-17 Production in Gut-Residing Immune Cells of 5xFAD Mice with Alzheimer's Disease Pathology., J Alzheimers Dis, vol. 61, no. 2, pp. 619-630, 2018.
I. Sala, Illán-Gala, I., Alcolea, D., Sánchez-Saudinós, M. Belén, Salgado, S. Andrés, Morenas-Rodriguez, E., Subirana, A., Videla, L., Clarimón, J., Carmona-Iragui, M., Ribosa-Nogué, R., Blesa, R., Fortea, J., and Lleo, A., Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease., J Alzheimers Dis, vol. 58, no. 3, pp. 909-918, 2017.
R. Sala-Llonch, Idland, A. - V., Borza, T., Watne, L. Otto, Wyller, T. Bruun, Brækhus, A., Zetterberg, H., Blennow, K., Walhovd, K. Beate, and Fjell, A. Martin, Inflammation, Amyloid, and Atrophy in The Aging Brain: Relationships with Longitudinal Changes in Cognition., J Alzheimers Dis, vol. 58, no. 3, pp. 829-840, 2017.
I. H. Salas, Callaerts-Vegh, Z., D'Hooge, R., Saido, T. C., Dotti, C. G., and De Strooper, B., Increased Insoluble Amyloid-β Induces Negligible Cognitive Deficits in Old AppNL/NL Knock-In Mice., J Alzheimers Dis, vol. 66, no. 2, pp. 801-809, 2018.
M. Saleem, Herrmann, N., Dinoff, A., Mielke, M. M., Oh, P. I., Shammi, P., Cao, X., Venkata, S. Lakshmi Va, Haughey, N. J., and Lanctôt, K. L., A Lipidomics Approach to Assess the Association Between Plasma Sphingolipids and Verbal Memory Performance in Coronary Artery Disease Patients Undertaking Cardiac Rehabilitation: A C18:0 Signature for Cognitive Response to Exercise., J Alzheimers Dis, vol. 60, no. 3, pp. 829-841, 2017.
H. Salem, Rocha, N. Pessoa, Colpo, G. Delevati, and Teixeira, A. Lucio, Moving from the Dish to the Clinical Practice: A Decade of Lessons and Perspectives from the Pre-Clinical and Clinical Stem Cell Studies for Alzheimer's Disease., J Alzheimers Dis, vol. 53, no. 3, pp. 1209-30, 2016.
H. Salem, Suchting, R., Gonzales, M. M., Seshadri, S., and Teixeira, A. L., Apathy as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Texas Alzheimer's Research and Care Consortium (TARCC) Cohort-Based Analysis., J Alzheimers Dis, vol. 92, no. 1, pp. 129-139, 2023.
K. Salgado-Puga, Rodríguez-Colorado, J., Prado-Alcalá, R. A., and Peña-Ortega, F., Subclinical Doses of ATP-Sensitive Potassium Channel Modulators Prevent Alterations in Memory and Synaptic Plasticity Induced by Amyloid-β., J Alzheimers Dis, vol. 57, no. 1, pp. 205-226, 2017.
S. P. Salloway, Sperling, R., Fox, N. C., Sabbagh, M. N., Honig, L. S., Porsteinsson, A. P., Rofael, H., Ketter, N., Wang, D., Liu, E., Carr, S., Black, R. S., and H Brashear, R., Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study., J Alzheimers Dis, vol. 64, no. 3, pp. 689-707, 2018.
S. Salloway, Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., Reichert, M., Ketter, N., Nejadnik, B., Guenzler, V., Miloslavsky, M., Wang, D., Lu, Y., Lull, J., Tudor, I. Cristina, Liu, E., Grundman, M., Yuen, E., Black, R., and H Brashear, R., Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease., N Engl J Med, vol. 370, no. 4, pp. 322-33, 2014.

Pages